Liver study measures drug levels in PBC patients
NCT ID NCT04950764
First seen May 20, 2026 · Last updated May 24, 2026 · Updated 1 time
Summary
This study looked at how the body handles the drug seladelpar in 24 adults with primary biliary cholangitis (PBC) and varying degrees of liver impairment. Researchers measured drug levels in the blood and urine to see how liver function affects the drug's breakdown. The goal was to gather information, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
American Research Corporation
San Antonio, Texas, 78215, United States
-
Arizona Liver Health
Chandler, Arizona, 85224, United States
-
Henry Ford Health System
Novi, Michigan, 48377, United States
-
Hospital General Universitario Gregorio Maran
Madrid, 28007, Spain
-
Inje University Busan Paik Hospital
Busan, South Korea
-
Kings College Hospital
London, SE5 9RS, United Kingdom
-
Kyungpook National University Hospital
Daegu, 41944, South Korea
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mercy Medical Center
Baltimore, Maryland, 21202, United States
-
NIHR BRC Centre for Liver and Gastrointestinal Research Birmingham
Birmingham, B15 2GW, United Kingdom
-
Pinnacle Clinical Research- SA
San Antonio, Texas, 78229, United States
-
Pusan National University Hospital
Busan, 49241, South Korea
-
Seoul National University Hospital
Seoul, 3080, South Korea
-
Severance Hospital Yonsei University Health System
Seoul, 3722, South Korea
-
Southern Therapy and Advanced Research LLC
Jackson, Mississippi, 39216, United States
-
The Liver Institute at Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
-
The Royal Free London NHS Foundation Trust
London, NW2 2QG, United Kingdom
-
University of California Davis
Sacramento, California, 95817, United States
-
University of Colorado Anschutz
Aurora, Colorado, 80045, United States
-
Weill Medical College of Cornell University
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.